Moody's Ba3 Rating for Freedom Bank Kazakhstan Offers Minor Credit Boost Amid Persistent Overvaluation and Structural Risks

What happened

Freedom Holding Corp.'s Kazakh banking subsidiary received its first Moody's rating of Ba3 with a stable outlook, a step toward international recognition that may slightly ease funding costs. However, the DeepValue report reveals FRHC's earnings collapsed from $376 million in 2024 to $85 million in 2025, driven by regulatory caps, tax hikes, and FX volatility in Kazakhstan. The report emphasizes extreme customer concentration, with one market-maker accounting for 56% of fee income, and ongoing sanctions probes that heighten operational risk. Despite the rating, FRHC trades at a trailing P/E of 165x on depressed earnings, with a base case valuation of $105 per share implying over 20% downside from current levels. The rating does not address core issues like loss-making telecom investments or the structural impact of new Kazakh taxes on profitability.

Implication

For investors, the Ba3 rating could modestly lower borrowing costs for Freedom Bank Kazakhstan, providing minor financial relief in a high-coupon debt environment. However, this does not mitigate the earnings collapse from $376m to $85m or the structural pressures from Kazakh commission caps and a 10% surtax on sovereign income. The DeepValue report's base case valuation of $105 per share, versus the current $132.55, suggests significant downside risk if normalized earnings remain weak. Key risks like reliance on a single market-maker, sanctions overhang, and $79.8m quarterly losses in the telecom segment persist unchanged. Therefore, the rating offers no rationale to alter the recommendation to avoid or trim exposure above $130, awaiting clearer profitability recovery or a lower entry near $90.

Thesis delta

The Moody's rating provides incremental credit validation that may slightly improve bank subsidiary funding, but it does not shift the core investment thesis. FRHC remains overvalued with a P/E of 165x on volatile earnings, heavy Kazakh regulatory exposure, and unaddressed concentration risks, all aligning with the DeepValue sell call. Investors should continue monitoring for earnings normalization or regulatory resolutions before considering a position change.